Predicting Response to Recombinant Human Erythropoietin
- Robert I. Abels, MD; and
- David H. Henry, MD
- The R.W. Johnson Pharmaceutical Research Institute; Raritan, NJ 08869 Graduate Hospital, Philadelphia, PA 19146
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been …
RSS Feeds









